Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

HDL Cholesterol: Is Higher Always Better?

HDL Cholesterol: Is Higher Always Better?

Only up to a point. A low HDL cholesterol is linked to higher heart risk, and across the usual range a higher level goes with lower risk. But very high HDL is not extra protection, and in large studies it has been tied to worse outcomes.

More important, raising HDL with medication has not prevented heart attacks. HDL is better understood as a signal about your metabolism than as a shield. The numbers to act on are the ones that count the harmful particles.

Key takeaways

  • The "good cholesterol" label holds for the middle of the range, not for the extremes.
  • In large population studies, people with very high HDL died at higher rates than people with moderately high HDL.
  • Drugs that raised HDL sharply did not lower cardiovascular events, and one caused harm.
  • Low HDL usually travels with high triglycerides and insulin resistance, which is where attention should go.

Why HDL got its good reputation

HDL particles carry cholesterol away from tissues and back to the liver. Decades of population studies found that people with higher HDL cholesterol had fewer heart attacks.

The link is strong. In a pooled analysis of 302,430 people without prior vascular disease, each 15 mg/dL higher HDL cholesterol was associated with a 22% lower risk of coronary heart disease.1 From findings like that came the idea that more HDL must always be better, and that raising it would protect the heart. Both ideas were later tested, and neither held up.

What happens at very high levels

Two Danish population studies followed 52,268 men and 64,240 women and compared HDL cholesterol with deaths from any cause. The relationship was U-shaped. Risk was high at the low end, fell through the middle, then rose again at the top.

GroupHDL level with the lowest death rateHDL level with clearly higher death rate
Men73 mg/dL116 mg/dL or more
Women93 mg/dL135 mg/dL or more

Men with HDL cholesterol of 116 mg/dL or more had about twice the death rate of men at the lowest-risk level, and women at 135 mg/dL or more had a 68% higher rate.2

Some caution is needed. This kind of study shows a pattern, not a cause, and the authors noted that the findings needed confirmation. The fair conclusion is not that high HDL is dangerous. It is that a very high number should not be read as protection, and it should not be used to wave away other risk factors.

What genetics showed

Some people inherit gene variants that raise HDL cholesterol for life. If HDL itself protected the heart, those people should have fewer heart attacks.

A large genetic study tested this. Carriers of a variant that raised HDL cholesterol had the same heart attack risk as non-carriers.3 The same method, applied to variants that raise LDL cholesterol, showed the expected increase in risk. The authors concluded that raising HDL cholesterol cannot be assumed to lower heart attack risk.3

The drug trials that failed

The clearest test was to raise HDL with medication in people at high risk and count events. Several large trials did this.

  • Niacin. A trial of 3,414 patients already on a statin tested added niacin. HDL cholesterol rose, but the trial was stopped after about three years because there was no benefit.4 A second, larger trial of a niacin-based treatment also found no reduction in major vascular events, along with more serious side effects.
  • The first CETP inhibitor. This class of drug raises HDL cholesterol sharply. The first trial was stopped early because deaths and cardiovascular events increased.
  • The second. HDL cholesterol rose by about a third, with no effect on cardiovascular events.
  • The third. In a trial of 12,092 patients, HDL cholesterol more than doubled and the rate of cardiovascular events was the same as with placebo.5

A fourth drug in the class did lower coronary events modestly. It also lowered non-HDL cholesterol, so the result does not rescue the idea that raising HDL is what helps.

Taken together, the trials show that the HDL number on a lab report can be pushed up without the heart being any safer.

What a low HDL signals

None of this makes low HDL meaningless. It is still a useful warning, mainly because of the company it keeps.

Low HDL cholesterol and raised triglycerides are both part of the metabolic syndrome, a cluster that also includes raised blood pressure, raised fasting glucose and central obesity. A European consensus statement advises labs to flag HDL cholesterol of 40 mg/dL or below.6

If your HDL is low, the useful questions are about what sits behind it:

Working on those drivers is what lowers risk. HDL often rises as a side effect, but it is not the goal.

What to focus on instead

Current guidelines set treatment goals for LDL cholesterol and non-HDL cholesterol and use ApoB selectively. Raising HDL is not among those goals. If you want one number from a standard panel that reflects the harmful particles, use non-HDL cholesterol.

How Cardio Res-Q looks at the same question

Both Cardio Res-Q assessments measure ApoB and Lp(a), which measure the particles that drive plaque. Their Cleveland Heart panel also reports oxidized LDL and small dense LDL. The labs also includes insulin, glucose and A1c, the metabolic tests that explain most low HDL results, plus hs-CRP. The Comprehensive Assessment is $775. The Enhanced Assessment is $999 and adds a CIMT ultrasound and a coronary calcium score.

For what you receive afterward, read what you leave with. To book, go to the Cardio Res-Q program page.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

My HDL is over 100 mg/dL. Should I be worried?

Not on that basis alone. Population studies link very high levels with worse outcomes, but they do not prove the HDL is the cause. Mention it to your clinician, and do not treat it as a reason to ignore a high LDL cholesterol, ApoB or blood pressure.

Should I try to raise my HDL?

Not as a goal in itself. Trials that raised HDL with medication did not reduce heart attacks. Regular activity, a healthy weight and not smoking are worth doing for their direct effect on risk, whatever happens to your HDL number.

What counts as a low HDL?

Labs commonly flag results of 40 mg/dL or below. A low result is a reason to look at triglycerides, blood sugar and waist size, since these often move together.

Does a high HDL cancel out a high LDL?

No. This is a common belief, and it is the main reason the "good cholesterol" label can mislead. A high LDL cholesterol or ApoB needs attention on its own terms.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009. PMID 19903920 · doi:10.1001/jama.2009.1619↩
  2. Madsen CM, et al. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J 2017. PMID 28419274 · doi:10.1093/eurheartj/ehx163↩
  3. Voight BF, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012. PMID 22607825 · doi:10.1016/S0140-6736(12)60312-2↩
  4. AIM-HIGH Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011. PMID 22085343 · doi:10.1056/NEJMoa1107579↩
  5. Lincoff AM, et al. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. N Engl J Med 2017. PMID 28514624 · doi:10.1056/NEJMoa1609581↩
  6. Nordestgaard BG, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 2016. PMID 27122601 · doi:10.1093/eurheartj/ehw152↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify